A trial investigating the use of hydroxychloroquine to treat patients with COVID-19 has quietly closed enrollment after failure to recruit enough participants, according to a report. Henry Ford Health System’s Will Hydroxychloroquine Impede or Prevent COVID-19 (WHIP COVID-19) trial was a randomized, double-blinded study that sought to recruit 3,000 volunteers, but according to Bridge Michigan, … Continue reading Hydroxychloroquine COVID-19 Study Paused Due to Lack of Participants